Skip to main content
The Journal of the Royal College of General Practitioners logoLink to The Journal of the Royal College of General Practitioners
. 1983 Oct;33(255):651–653.

Use of amantadine in influenza: a second report

H J Rose
PMCID: PMC1973054  PMID: 6644670

Abstract

Clinical influenza attacked 304 out of 576 boys at a west country boarding school. Influenza A/ENG/333/80 (H1N1), a drift from A/USSR/92/77, was isolated from 14 out of 40 throat swabs. Pre-epidemic sera from 64 new boys showed that 54 already had antibodies to H1N1 and 40 of them had antibodies to this novel variant. Nevertheless, when their serum was re-examined post-epidemically, 36 showed a rise in antibody, indicating that infection had occurred.

One hundred and twenty-six junior boys were given amantadine and, of these, 22 (17.4 per cent) developed influenza, whereas 218 (57 per cent) of 382 boys who did not take amantadine had influenza. The immune status was known for 64 boys, 43 of whom were given amantadine. Only five (11.6 per cent) became clinically ill while taking the drug, whereas 10 (47.6 per cent) of the remaining 21 boys became ill. When their serum was re-examined, it was found that 20/43 of those taking amantadine and 5/21 of those not taking the drug had subclinical infection. The two groups were comparable in their pre-epidemic antibody status and all lived within the same environment during the outbreak.

It is concluded that amantadine secured a reduction in clinical influenza without protecting significantly against subclinical infection, thus allowing subtype specific immunity to develop.

Full text

PDF
651

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Dolin R., Reichman R. C., Madore H. P., Maynard R., Linton P. N., Webber-Jones J. A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection. N Engl J Med. 1982 Sep 2;307(10):580–584. doi: 10.1056/NEJM198209023071002. [DOI] [PubMed] [Google Scholar]
  2. Hope-Simpson R. E. Epidemic mechanisms of type A influenza. J Hyg (Lond) 1979 Aug;83(1):11–26. doi: 10.1017/s002217240002578x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Hoskins T. W., Davies J. R., Smith A. J., Miller C. L., Allchin A. Assessment of inactivated influenza-A vaccine after three outbreaks of influenza A at Christ's Hospital. Lancet. 1979 Jan 6;1(8106):33–35. doi: 10.1016/s0140-6736(79)90468-9. [DOI] [PubMed] [Google Scholar]
  4. Rose H. J. The use of amantadine and influenza vaccine in a type A influenza epidemic in a boarding school. J R Coll Gen Pract. 1980 Oct;30(219):619–621. [PMC free article] [PubMed] [Google Scholar]
  5. Sabin A. B. Amantadine and influenza: evaluation of conflicting reports. J Infect Dis. 1978 Oct;138(4):557–568. doi: 10.1093/infdis/138.4.557. [DOI] [PubMed] [Google Scholar]
  6. Van Voris L. P., Betts R. F., Hayden F. G., Christmas W. A., Douglas R. G., Jr Successful treatment of naturally occurring influenza A/USSR/77 H1N1. JAMA. 1981 Mar 20;245(11):1128–1131. doi: 10.1001/jama.245.11.1128. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of the Royal College of General Practitioners are provided here courtesy of Royal College of General Practitioners

RESOURCES